+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Byetta"

Peptide Based Metabolic Disorders Therapeutics Market Report 2025 - Product Thumbnail Image

Peptide Based Metabolic Disorders Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
GLP-1 Agonists Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

GLP-1 Agonists Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Byetta is a brand of exenatide, a drug used to treat type 2 diabetes. It is a member of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. Byetta is an injectable medication that helps to control blood sugar levels by increasing the amount of insulin released by the pancreas. It is typically used in combination with other diabetes medications. The Endocrine and Metabolic Disorders Drugs market is a large and growing market, with a wide range of products available. Byetta is one of the most popular drugs in this market, and is used by millions of people around the world. Companies in the Byetta market include Eli Lilly, Novo Nordisk, Sanofi, Merck, and AstraZeneca. Show Less Read more